Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Imatinib Mesylate Tablets

Approval Number

国药准字H20253513

Company

广州科锐特药业有限公司

Registration Date

March 4, 2025

Drug Information

Generic Name

甲磺酸伊马替尼片

Dosage Form

片剂

Strength

0.1g（按C₂₉H₃₁N₇O计）

Drug Type

化学药品

Registration Date

March 4, 2025

Company Information

Applicant Company

Company Name

广州科锐特药业有限公司

Company Address

广州市黄埔区春分路80号

Manufacturing Company

Company Name

广州科锐特药业有限公司

Company Address

广州市黄埔区春分路80号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

甲磺酸伊马替尼片 - NMPA 批准文号 | MedPath